Viewing Study NCT01321567

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-01-29 @ 12:57 PM
Study NCT ID: NCT01321567
Status: COMPLETED
Last Update Posted: 2023-07-24
First Post: 2011-03-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis
Sponsor: Eisai Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Reflux Esophagitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None rabeprazole sodium View
None refractory reflux esophagitis View